Oberland Capital

Investment firm

Oberland Capital

Private equity, Venture debt

WebsiteCrunchbase profileNew York·United States6known portfolio companies8people tracked15co-investors

Oberland Capital is a private equity firm and venture debt provider. Based in New York, United States. Known portfolio companies include Opus Genetics, Primmune Therapeutics, Verastem Oncology, Biohaven Pharmaceutical, ImmunityBio and ClearPoint Neuro, 6 companies in all.

Is Oberland Capital a fit for your startup?

Paste your website. AI checks the fit and scores every other investor too.

Investment focus

Focus
BiotechDiagnosticsDrug DiscoveryMedical DevicesPharmaRoyalty FinancingStructured Healthcare FinanceTherapeutics

Who to pitch at Oberland Capital

Oberland Capital portfolio companies (6)

  • Opus Genetics
  • Primmune Therapeutics
  • Verastem Oncology
  • Biohaven Pharmaceutical
  • ImmunityBio
  • ClearPoint Neuro

Co-investors

Funds that share portfolio companies with Oberland Capital.

Similar funds

Showing 20 of 100

About Oberland Capital

The firm's listing covers sectors Healthcare and Travel, and focus areas Biotech, Diagnostics, Drug Discovery and Medical Devices; known deals cluster at Late-Stage, Series A and Series B.

Of the 8 people on file at Oberland Capital, Andrew Rubinstein (Managing Partner), Sarah Drew Siber (Partner) and Cecilia Gonzalo (Partner) are listed as the contacts to approach first.

Oberland Capital shares portfolio companies with 15 other investment firms, among them Marshall Wace, Michigan Capital Network and Woodward Angels.

Frequently asked questions

What is Oberland Capital?

Oberland Capital is a private equity firm and venture debt provider based in New York, United States, with a known portfolio of 6 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.

What does Oberland Capital invest in?

Listed sectors include Healthcare and Travel; listed focus areas include Biotech, Diagnostics, Drug Discovery and Medical Devices. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.

What stage does Oberland Capital invest at?

The known deals of Oberland Capital include Late-Stage, Series A and Series B rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.

Who should I pitch at Oberland Capital?

3 of the 8 people on file at Oberland Capital are listed as contacts for the firm. All 8 have their own profile page.

How do I contact Oberland Capital?

Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The 8 people attached to the firm have their own pages, each showing whether an address is on file for them.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal